Back to Search
Start Over
Differences in prescription patterns between real-world outpatients with bipolar I and II disorders in the MUSUBI survey
- Source :
- Asian Journal of Psychiatry. 67:102935
- Publication Year :
- 2022
- Publisher :
- Elsevier BV, 2022.
-
Abstract
- OBJECTIVE There is limited information available on the prescription of psychotropic agents to patients with bipolar I (BD-I) and bipolar II disorder (BD-II). The purpose of this study was to investigate the characteristics of drug therapy in BD-I and BD-II outpatients, particularly with regard to antidepressants. METHODS In 2017, the MUlticenter treatment SUrvey for BIpolar disorder in Japanese psychiatric clinics (MUSUBI) study collected data on current mental status, medications, and other factors from 2774 outpatients with BD-I or BD-II. RESULTS There were significant differences in the rates of prescriptions for mood stabilizers, antipsychotics and antidepressants. Mood stabilizers and antipsychotics were prescribed at higher rates to patients with BD-I (mood stabilizers; BD-I 86.0%, BD-II 80.8%, p
- Subjects :
- medicine.medical_specialty
Bipolar Disorder
chemistry.chemical_compound
Bipolar II disorder
Escitalopram
Pharmacotherapy
Antimanic Agents
Internal medicine
Outpatients
Humans
Medicine
Duloxetine
Bipolar disorder
Medical prescription
General Psychology
business.industry
General Medicine
medicine.disease
Psychiatry and Mental health
Prescriptions
Mood
chemistry
business
Psychotropic Agent
Antipsychotic Agents
medicine.drug
Subjects
Details
- ISSN :
- 18762018
- Volume :
- 67
- Database :
- OpenAIRE
- Journal :
- Asian Journal of Psychiatry
- Accession number :
- edsair.doi.dedup.....44a8ece3e06f58f79c3df3935d214bce